These terms and conditions govern your use of the website alphaminr.com and its related
services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr,
(“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms
include the provisions in this document as well as those in the Privacy Policy. These terms may
be modified at any time.
Subscription
Your subscription will be on a month to month basis and automatically renew every month. You may
terminate your subscription at any time through your account.
Fees
We will provide you with advance notice of any change in fees.
Usage
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Limitation of Liability
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The
service is provided “As is”. The materials and information accessible through the Service are
solely for informational purposes. While we strive to provide good information and data, we make
no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO
YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY
OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR
(2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE
CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR
CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision
shall not affect the validity or enforceability of the remaining provisions herein.
Privacy Policy
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal
information when we provide our service (“Service”). This Privacy Policy explains how
information is collected about you either directly or indirectly. By using our service, you
acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy
Policy, please do not use our Service. You should contact us if you have questions about it. We
may modify this Privacy Policy periodically.
Personal Information
When you register for our Service, we collect information from you such as your name, email
address and credit card information.
Usage
Like many other websites we use “cookies”, which are small text files that are stored on your
computer or other device that record your preferences and actions, including how you use the
website. You can set your browser or device to refuse all cookies or to alert you when a cookie
is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not
function properly. We collect information when you use our Service. This includes which pages
you visit.
Sharing of Personal Information
We use Google Analytics and we use Stripe for payment processing. We will not share the
information we collect with third parties for promotional purposes.
We may share personal information with law enforcement as required or permitted by law.
Proxy
Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
Filed
by the Registrant
Filed by a Party other than the Registrant
o
Check
the appropriate box:
o
Preliminary
Proxy Statement
o
Confidential,
for Use of the Commission Only (as permitted by Rule14a-6(e)(2))
Definitive
Proxy Statement
o
Definitive
Additional Materials
o
Soliciting
Material Pursuant to Sec. 240.14a-12
THE
HERZFELD CARIBBEAN BASIN FUND, INC.
(Name
of Registrant as Specified in Its Charter)
(Name
of Person(s) Filing Proxy Statement, if other than Registrant)
Payment
of Filing Fee (Check the appropriate box):
No
fee required.
o
Fee
computed on table below per Exchange Act Rules14a-6(i)(1) and 0-11.
1)
Title
of each class of securities to which transactions applies:
2)
Aggregate
number of securities to which transaction applies:
3)
Per
unit price or other underlying value of transaction computed pursuant to Exchange Act Rule0-11 (Set forth the amount on which
the filing fee is calculated and state how it was determined):
4)
Proposed
maximum aggregate value of transaction:
5)
Total
fee paid:
o
Fee
paid previously with preliminary materials.
o
Check box if any part of the fee is offset as provided by Exchange Act Rule0-11(a)(2) and identity the
filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or
Schedule and the date of its filing.
1)
Amount
Previously Paid:
2)
Form,
Schedule or Registration Statement No.:
3)
Filing
Party:
4)
Date
Filed:
The
Herzfeld Caribbean Basin Fund, Inc.
NOTICE
OF ANNUAL MEETING OF STOCKHOLDERS
November
14, 2024
Miami
Beach, Florida
September
30, 2024
TO
THE STOCKHOLDERS OF
THE
HERZFELD CARIBBEAN BASIN FUND, INC.:
The
Annual Meeting of Stockholders of The Herzfeld Caribbean Basin Fund, Inc. (the Fund) will be held on November 14, 2024,
at 10:00 a.m. Eastern Time at the Main Conference Room in Murano at Portofino, 1000 South Pointe Drive, Miami Beach, Florida, or such
other location and time as the officers of the Fund deem necessary, including by means of remote communication, for the following purposes
(the Annual Meeting):
Proposal
(1): To elect two Class I directors; and,
Other
Business: To transact such other business as may properly come before the meeting and any adjournments thereof.
The
subjects referred to above are discussed in detail in the proxy statement accompanying this notice. The Board of Directors, including
all of the Directors who are not interested persons (as defined in the Investment Company Act of 1940, as amended) of the
Fund, unanimously recommends that you vote
FOR
the Boards nominees for director.
Each
stockholder is invited to attend the Annual Meeting in person. Stockholders of record at the close of business on September 18, 2024,
have the right to vote at the meeting.
If you plan to attend the meeting in person, please pre-register to obtain an admission ticket
to facilitate entry through security at the Annual Meeting. Valid, government-issued photo identification is required to enter the meeting.
Please see page 11 of this proxy statement for information about how to pre-register.
If you cannot be present at the Annual Meeting,
we urge you to fill in, sign, and promptly return the enclosed WHITE proxy card in order that the Annual Meeting can be held without
additional expense and a maximum number of shares may be voted.
Erik M. Herzfeld
President
Important
Notice Regarding the Availability of Proxy Materials for the
Stockholder
Meeting to Be Held on November 14, 2024
The
proxy statement and annual report to stockholders are available at www.herzfeld.com/cuba or by calling the Fund at
800-TJH-FUND
(854-3863) or 305-777-1660.
YOUR
VOTE IS IMPORTANT
NO
MATTER HOW MANY SHARES YOU OWNED ON THE RECORD DATE.
PLEASE
INDICATE YOUR VOTING INSTRUCTIONS ON THE ENCLOSED PROXY CARD, DATE, SIGN AND RETURN IT IN THE ENVELOPE PROVIDED, WHICH IS ADDRESSED
FOR YOUR CONVENIENCE AND NEEDS NO POSTAGE IF MAILED IN THE UNITED STATES. IN ORDER TO AVOID THE ADDITIONAL EXPENSE TO THE FUND OF
FURTHER SOLICITATION, WE ASK YOUR COOPERATION IN VOTING YOUR PROXY PROMPTLY. THE PROXY IS REVOCABLE AT ANY TIME PRIOR TO ITS USE.
The
Herzfeld Caribbean Basin Fund, Inc.
119
Washington Avenue, Suite 504, Miami Beach, Florida 33139
PROXY
STATEMENT
ANNUAL
MEETING OF STOCKHOLDERS TO BE HELD ON
NOVEMBER
14, 2024
This
statement is furnished in connection with the solicitation of proxies by the Board of Directors of The Herzfeld Caribbean Basin Fund,
Inc. (the Fund), a Maryland corporation, for use at the Annual Meeting of Stockholders (the Annual Meeting)
to be held at the Main Conference Room in Murano at Portofino, 1000 South Pointe Drive, Miami Beach, Florida, on November 14, 2024 at
10:00 a.m. Eastern Time, or such other location and time as the officers of the Fund deem necessary, including by means of remote communication.
Stockholders of the Fund are being asked to vote on the election of two Class I directors.
Proxies
may be solicited by mail, telephone, email and personal interview. The Fund has also requested brokers, dealers, banks or voting trustees,
or their nominees, to forward proxy material to the beneficial owners of stock of record. You may revoke your proxy at any time prior
to the exercise thereof by submitting a written notice of revocation or subsequently executed proxy to the Fund at the address set forth
above. Signing and mailing the proxy will not affect your right to give a later-dated proxy or to attend the Annual Meeting and vote
your shares in person. There is no stockholder statutory right of appeal or dissident with respect to any matters to be voted on at the
Annual Meeting. The cost of soliciting proxies will be paid by the Fund. This proxy statement is expected to be distributed to stockholders
on or about October 4, 2024.
THE
PERSON NAMED IN THE ACCOMPANYING PROXY WILL VOTE THE NUMBER OF SHARES REPRESENTED THEREBY AS DIRECTED OR, IN THE ABSENCE OF SUCH DIRECTION,
FOR THE NOMINEE FOR DIRECTOR AND TO TRANSACT SUCH OTHER BUSINESS THAT MAY PROPERLY COME BEFORE THE MEETING AND ANY ADJOURNMENTS THEREOF.
EVEN
IF YOU EXPECT TO ATTEND THE ANNUAL MEETING, YOU ARE REQUESTED TO COMPLETE, SIGN AND DATE THE ENCLOSED PROXY CARD AS SOON AS POSSIBLE.
Stockholders who wish to attend the Annual Meeting should pre-register to obtain an admission ticket to facilitate entry through security
at the Annual Meeting. Valid, government-issued photographic identification is required to enter the meeting. If you plan to attend,
please see page 11 for additional information on pre-registration and admission to the Annual Meeting.
The
Funds Common Stock trades on the NASDAQ Capital Market under the ticker symbol CUBA.
On
September 18, 2024, the record date for determination of stockholders entitled to receive notice of and to vote at the Annual Meeting,
or any adjournment thereof, there were issued and outstanding 16,548,313 shares of Common Stock of the Fund, each entitled to one vote,
constituting all of the Funds then outstanding securities.
At
the Annual Meeting, a quorum shall consist of the holders of a majority of the outstanding shares of the Common Stock of the Fund entitled
to vote at the meeting. If a quorum is present, a plurality of all votes cast at the Annual Meeting shall be sufficient for the approval
of the Proposal. Under Maryland law, abstentions and broker non-votes (i.e., shares held by brokers or a nominee as to which (i) instructions
have not been received from the beneficial owner or the persons entitled to vote and (ii) the broker does not have discretionary voting
power on a particular matter) will be included for purposes of determining whether a quorum is present at the Annual Meeting, but do
not constitute votes cast, and therefore, will not be counted for purposes of determining whether matters to be voted upon at the Annual
Meeting have been approved.
The
holders of a majority of the outstanding shares of the Common Stock of the Fund entitled to vote at the meeting, present in person or
by proxy, have the power to adjourn the meeting to any specific time or times, including to solicit proxies, and no notice of any such
adjourned meeting need be given to stockholders absent or otherwise. If an adjournment is proposed, the person named as proxy will vote
thereon according to his best judgment in the interest of the Fund.
1
The
Fund will furnish, without charge, a copy of its annual report for its fiscal year ended June 30, 2024, to any stockholder requesting
such report.
Requests
for the annual report or semi-annual report should be made in writing to the Fund at the address set forth above or by calling the Fund
at 800-TJH-FUND (854-3863) or 305-777-1660.
ELECTION
OF DIRECTORS
(Proposal
1)
Two
directors are to be elected at the Annual Meeting. Pursuant to the Funds By-Laws, the directors are classified into three classes
with respect to the year of expiration of their terms of office. Because the Funds Class I directors term of office will
expire in 2024, the Annual Meeting is being held for the election of such directors. The remaining Class II and Class III directors
terms of office will expire in 2025 and 2026, respectively.
If
authority is granted on the accompanying proxy card to vote in the election of the directors, it is the intention of the person named
in the proxy to vote at the Annual Meeting for the election of the nominees named below, who have each consented to being named in the
proxy statement and to serve if elected. If a nominee is unavailable to serve for any reason, the person named as proxy will vote for
such other nominee selected by the Board of Directors, or the Board may reduce the number of directors as provided in the Funds
By-Laws. The Fund currently knows of no reason why the nominees listed below would be unable or unwilling to serve if elected.
As
of September 18, 2024, the Funds Board of Directors consisted of 5 members. The Class I directors of the Fund, Ms. Cecilia L.
Gondor and Ms. Kay W. Tatum, are the nominees for election, and each nominees current term as a director will expire on the date
of the Annual Meeting or when her successor is elected and qualified. Each nominee, if elected, will serve until her successor has been
elected and qualified.
Certain
information regarding the nominees as well as the current directors and executive officers of the Fund is set forth below. Unless otherwise
noted, the mailing address of each director and executive officer is c/o The Herzfeld Caribbean Basin Fund, Inc., 119 Washington Avenue,
Suite 504, Miami Beach, FL, 33139.
Name,
Address
and Age
Position(s)
Held with
Fund
Term of
Office* and
Length of
Time Served
Principal
Occupation(s)
During Past 5 Years
Number
of
Portfolios in
Complex
Overseen by
Director
Other
Directorships
Held by
Director
Nominee
for Director Independent Directors
Cecilia
L. Gondor
Age: 62
Director,
Class I
Current
term expires 2024. 2014 to present.
Managing
Member of LM Management, a real estate management business, 2014-present.
1
None
Kay
W. Tatum, Ph.D., CPA
Age: 72
Director,
Class I
Current
term expires 2024. 2007 to present.
Associate
Professor of Accounting, University of Miami Herbert Business School, 1992-present.
1
None
2
Current
Directors and Officers
Independent Directors:
Cecilia
L. Gondor
See
Nominees for Director Independent Directors above
Kay
W. Tatum, Ph.D., CPA
See
Nominees for Director Independent Directors above
John
A. Gelety
Age: 56
Director,
Class II
Current
term expires 2025. 2011 to present.
Attorney
and Partner at Greenspoon Marder, LLP, corporate practice group, 2016-present.
1
None
Ann
S. Lieff
Age: 72
Director,
Class II
Current
term expires 2025. 1998 to present.
President
of the Lieff Company, a management consulting firm that offers ongoing advisory services as a corporate director, 1998-present.
1
None
Interested
Person:
Thomas
J. Herzfeld**
Age:79
Chairman,
Director, Class III, and Portfolio Manager
Current
term expires 2026. 1993 to present.
Thomas
J. Herzfeld Advisors, Inc., serving as Chairman, 1984-present; and Portfolio Manager, 1984-present.
1
None
Officers:
Erik
M. Herzfeld
Age: 51
President;
Portfolio Manager
2007
to present 2016 to present
Thomas
J. Herzfeld Advisors, Inc., serving as President, 2016-present; and Portfolio Manager, 2007-present.
N/A
Ryan
M. Paylor
Age: 43
Portfolio
Manager
2019
to present
Thomas
J. Herzfeld Advisors, Inc., serving as Portfolio Manager, 2012-present.
NA
NA
Thomas
K. Morgan
Age: 65
Chief
Compliance Officer
2018
to present
Thomas
J. Herzfeld Advisors, Inc., serving as Chief Compliance Officer, 2018 to present; Managing Partner of TMorgan Advisers Limited Liability
Company, providing compliance consulting and outsourced chief compliance officer services, 2015 to present.
NA
NA
Zachary
P. Richmond
Age: 44
Treasurer
2020
to present
Ultimus
Fund Solutions, LLC, serving as Vice President, Director of Financial Administration, February 2019-present.
N/A
N/A
Alice
H. Tham
Age: 34
Secretary
2019
to present
Thomas
J. Herzfeld Advisors, Inc., serving as Operations Manager, 2012-present.
NA
NA
*
Each
director serves a three-year term after which the director may be re-elected for additional three-year terms.
**
An
interested person (as defined in the Investment Company Act of 1940, as amended (1940 Act)) of the Fund because
he is a control person, director and employee of Thomas J. Herzfeld Advisors, Inc. (the Adviser).
3
Ownership
of Fund Securities by Directors
Name
Dollar
Range of
Equity Securities in
the Fund***
Number
of Shares
Held***
Percent
of Class***
Aggregate
Dollar Range
of Equity Securities in All
Funds Overseen by
Director or Nominee in
Credit Suisse Family of
Investment
Companies****
Interested
Directors:
Thomas
J. Herzfeld
Over
$100,000
1,590,111
9.61%
Independent
Directors:
Ann
S. Lieff
$50,001-$100,000
36,358
0.22%
Cecilia
L. Gondor
$10,001
- $50,000
41,960
0.25%
John
A. Galety
$10,001
- $50,000
6,434
0.04%
Kay
W. Tatum, Ph.D., CPA
$0
- $10,000
5,027
0.03%
All
directors as a group (five persons)
N/A
1,679,890
10.15%
***
As
of September 18, 2024
****
There
are no other funds in the family of investment companies
None
of the Independent Directors, and no immediate family members of any Independent Director, owns securities of the Funds investment
adviser, or any control person of the Funds investment adviser. As of September 18, 2024, the directors (5 persons) beneficially
owned an aggregate of 10.15% of the Funds outstanding shares on that date.
BOARD
AND COMMITTEE STRUCTURE
The
Funds Board of Directors consists of 5 members. Thomas J. Herzfeld is an interested person (as such term is defined
in the 1940 Act) who currently serves as the Chairman of the Board. The Board believes that Mr. Herzfelds service as Chairman
is appropriate and benefits stockholders due to his personal and professional stake in the quality of services provided to the Fund.
The Independent Directors believe that they can act independently and effectively without having an Independent Director serve as Chairman.
Nonetheless, as currently composed, the Independent Directors constitute a substantial majority of the Board.
4
While
the Fund currently does not have a policy requiring a lead Independent Director, the Board believes that having an Independent Director
fill the lead director role is appropriate. Mr. Gelety currently serves as the lead Independent Director of the Board. The lead Independent
Director, among other things, works with the Chairman of the Board in the preparation of the agenda for each Board meeting and in determining
the need for special meetings of the Board, chairs any meeting of the Independent Directors in executive session, facilitates communications
between other members of the Board and the Chairman of the Board or the President of the Fund and otherwise consults with the Chairman
of the Board or the President on matters relating to corporate governance and Board performance.
The
chairperson of each Board committee and every member of each Board committee is an Independent Director, which yields similar benefits
with respect to the functions and activities of the various Board committees. Through the committees, the Independent Directors consider
and address important matters involving the Fund, including those presenting conflicts or potential conflicts of interest for management.
The Independent Directors also regularly meet outside the presence of management with Fund counsel and with the Fund’s auditor.
The Board has determined that its committees help ensure that the Fund has effective and independent governance and oversight. The Board
also believes that its leadership structure facilitates the orderly and efficient flow of information to the Independent Directors from
Fund management.
The
Board of Directors of the Fund held four regular meetings during the Fund’s fiscal year ended June 30, 2024. Each of the directors
attended at least 75% of the aggregate number of meetings of the Board of Directors and of each committee of which he or she was a member.
Director
Qualifications
The
Board believes that the significance of each director’s experience, qualifications, attributes or skills is an individual matter
(meaning that experience that is important for one director may not have the same value for another) and that these factors are best
evaluated at the Board level, with no single director, or particular factor, being indicative of the Board’s effectiveness. The
Board determined that each of the directors is qualified to serve as such based on a review of the experience, qualifications, attributes
and skills of each director. In reaching this determination, the Board has considered a variety of criteria, including, among other things:
character and integrity; ability to review critically, evaluate, question and discuss information provided, to exercise effective business
judgment in protecting stockholder interests and to interact effectively with the other directors, the Adviser, other service providers,
counsel and the independent registered public accounting firm or independent accountants; and willingness and ability to commit the time
necessary to perform the duties of a director. Each director’s ability to perform his or her duties effectively is evidenced by
his or her experience or achievements in the following areas: management or Board experience in the investment management industry or
companies or organizations in other fields, educational background and professional training; and experience as a director of the Fund.
In addition, the Board values the diverse skill sets and experiences that each director contributes. The Board considers that its diversity
as a whole is as a result of a combination of directors and the various perspectives that each director provides as a result of his or
her present experiences and his or her background. Information discussing the specific experience, skills, attributes and qualifications
of each director which led to the Board’s determination that the directors should serve in this capacity is provided below.
Thomas
J. Herzfeld has served as Chairman of the Board since inception of The Herzfeld Caribbean Basin Fund, Inc. in 1993. In addition, he is
the Chairman of Thomas J. Herzfeld Advisors, Inc., the Fund’s investment adviser. Mr. Herzfeld entered the securities industry
in 1968, was founder of a New York Stock Exchange member firm in 1970 and was the Chairman and President of FINRA member firm Thomas
J. Herzfeld Co., Inc., formed in 1981.
Ann
S. Lieff joined the Board in 1998. Ms. Lieff is President of Lieff Company, a management consulting firm that offers ongoing advisory
services as a corporate director. Previously she served as Chief Executive Officer of Spec’s Music for 18 years, from 1980-1998;
Specs was one of the largest music retail chain stores in the Southeastern region of the United States for many decades.
Kay
W. Tatum, Ph.D., CPA, joined the Board in 2007. Dr. Tatum is an Associate Professor of Accounting at the Miami Herbert School of Business,
where she has been since 1986. She also served as Chair of the Department of Accounting from 2004 to 2008.
5
John
A. Gelety, Esq. joined the Board in 2011 and has been designated the lead Independent Director. Mr. Gelety is a practicing attorney who
specializes in business law, with a concentration on domestic and cross-border mergers acquisitions, private equity and commercial
transactions.
Cecilia
L. Gondor joined the Board in 2014. Ms. Gondor is a Managing Member of LM Management, a real estate management business. Ms. Gondor
served as the Secretary/Treasurer of Fund from its inception until her retirement in May 2014. She also served as Executive Vice President
of the Adviser from 1984 through the date of her retirement. Additionally, she was the Executive Vice President of Thomas J. Herzfeld
Co. Inc., a broker-dealer, from 1984 through 2010, when the broker-dealer ceased operations. Ms. Gondor is a freelance financial
writer and has written extensively on closed-end funds.
Specific
details regarding each director’s principal occupations during the past five years are included in the table above. The summaries
set forth above as to the experience, qualifications, attributes and/or skills of the directors do not constitute holding out the Board
or any director as having any special expertise or experience, and do not impose any greater responsibility or liability on any such
person or on the Board as a whole than would otherwise be the case.
Risk
Oversight
While
responsibility for the day-to-day operations for the Fund, including certain risk management functions addressed in policies and procedures
relating to the Fund, resides with the Adviser, the Board actively performs a risk oversight function, both directly and through its
committees, as described below. The Board and its audit committee (the “Audit Committee”) exercise a risk oversight function
through regular and ad hoc Board and Audit Committee meetings during which the Board and the Audit Committee meet with representatives
of the Adviser and other service providers. The Board also periodically receives reports regarding the Fund’s and the Adviser’s policies
and procedures, and reviews and approves changes to the Fund’s policies and procedures. The Audit Committee also meets regularly with
the Fund’s independent registered public accounting firm to discuss internal controls and financial reporting matters, among other things.
The Board and Audit Committee routinely receive reports from the Fund’s officers and the Adviser on a variety of other risk areas relating
to the Fund, including, without limitation, investment risks, liquidity risks, valuation risks, cybersecurity risks, and operational
risks, as well as more general business risks. In addition, the Board consults with Fund counsel both during and, to the extent required,
between meetings of the Board and the Audit Committee.
The
Board also meets regularly with the Fund’s Chief Compliance Officer (“CCO”), who reports directly to the Board. The CCO has
responsibility for annually testing the compliance procedures of the Fund and its service providers. The CCO regularly discusses issues
related to compliance with the Board and provides a quarterly report to the Board regarding certain Fund compliance matters.
Committees
of the Board
The
Board has formed an Audit Committee and a Nominating and Governance Committee.
Audit
Committee.
The Audit Committee of the Board currently consists of Mr. Gelety, Ms. Gondor, Ms. Lieff and Dr. Tatum, none of whom is
an “interested person” of the Fund. Each member of the Audit Committee is considered independent under the applicable NASDAQ
Capital Market listing standards. The Board has determined that Dr. Tatum qualifies as an “audit committee financial expert”
and that she is “independent” of the Fund as such terms are defined in Item 3 of Form N-CSR. Dr. Tatum serves as Chair of
the Audit Committee. The Audit Committee met two times during the fiscal year ended June 30, 2024. The Board has adopted a written charter
for the Audit Committee, which is available on the Fund’s website at www.herzfeld.com/cuba.
The
Audit Committee reviews the scope of the audit by the Fund’s independent registered public accounting firm, confers with the independent
accountants with respect to the audit and the internal accounting controls of the Fund and with respect to such other matters as may
be important to an evaluation of the audit and the financial statements of the Fund, and makes recommendations with respect to the selection
of the independent registered public accounting firm for the Fund.
6
Audit
Committee Report
. The Audit Committee has reviewed and discussed the Fund’s audited financial statements for the fiscal year
ended June 30, 2024 with Fund management. Further, the Audit Committee has discussed with Tait, Weller Baker LLP (“Tait Weller”),
the Fund’s independent registered public accounting firm, the matters required to be discussed by Public Company Accounting Oversight
Board (“PCAOB”) Auditing Standard 1301 (Communications with Audit Committees). The Audit Committee has received the written
disclosures and a letter from Tait Weller required by PCAOB Rule 3526 (Communication with Audit Committees Concerning Independence) and
has discussed with Tait Weller their independence. Based upon the foregoing, the Audit Committee recommended to the Board of Directors
that the audited financial statements of the Fund be included in the Fund’s annual report to stockholders for filing with the U.S.
Securities and Exchange Commission (“SEC”) for the fiscal year ended June 30, 2024.
Kay
W. Tatum
John A. Gelety
Cecilia Gondor
Ann S. Lieff
Nominating
and Governance Committee.
The Nominating and Governance Committee (the “Nominating Committee”) is currently comprised
of Mr. Gelety, Ms. Gondor, Ms. Lieff, and Dr. Tatum, each of whom is an Independent Director under the 1940 Act and under NASDAQ Capital
Market listing standards. Mr. Gelety serves as Chair of the Nominating Committee. During the fiscal year ended June 30, 2024, the Nominating
Committee met twice.
The
Nominating Committee is responsible for reviewing and recommending qualified candidates in the event that a directorship is vacated or
created. The Nominating Committee will not consider nominees recommended by stockholders. The Nominating Committee believes that candidates
for director should have certain minimum qualifications, including (i) the ability to apply good business judgment; (ii) the ability
to properly exercise their duties of loyalty and care; (iii) proven leadership capabilities, high integrity and moral character, significant
business experience and a high level of responsibility within their chosen fields; (iv) the ability to quickly grasp complex principles
of business, finance, international transactions and the regulatory environment in which investment companies must operate; and (v) the
ability to read and understand basic financial statements. The Nominating Committee retains the right to modify these minimum qualifications
from time to time. In general, candidates will be preferred who hold an established senior or executive level position in business, finance,
law, education, research or government. The Nominating Committee’s process for identifying and evaluating nominees is as follows:
in the case of incumbent directors whose terms of office are set to expire, the Nominating Committee reviews such directors’ overall
service to the Fund during their term, including the number of meetings attended, level of participation, quality of performance, and
transactions of such directors with the Fund, if any, during their term, and confirms their independence, if applicable. In the case
of new director candidates, the Nominating Committee first determines whether the nominee must be independent for purposes of the NASDAQ
Capital Market and whether the candidate must be considered an Independent Director under the 1940 Act. In either case, determinations
are based upon the Fund’s charter and bylaws, applicable securities laws, the rules and regulations of the SEC, and the advice
of counsel, if necessary. The Nominating Committee then uses its network of contacts to compile a list of potential candidates, but may
also engage, if it deems appropriate, a professional search firm. The Nominating Committee then meets to discuss and consider such candidates’
qualifications and recommend the nominee.
The Board has adopted a written charter for the Nominating
Committee, which is available on the Fund’s website at www.herzfeld.com/cuba.
Stockholders
and other interested parties may contact the Board or any member of the Board by mail. To communicate with the Board or any member of
the Board, correspondence should be addressed to the Fund, Attention Board of Directors. All such correspondence should be sent c/o the
Fund at 119 Washington Avenue, Suite 504, Miami Beach, Florida, 33139.
Director
Compensation
For
the fiscal year ended June 30, 2024 the aggregate Director compensation paid by the Fund was $133,800. The compensation paid by the Fund
to each of its directors serving during the fiscal year ended June 30, 2024 is set forth in the compensation table below. Directors are
also reimbursed for related business expenses. Directors who are current employees or officers of the Fund’s investment adviser
(currently Mr. T. Herzfeld) are not paid compensation for their service as a director. None of the other directors serves on the Board
of any other registered
7
investment company to which the Fund’s investment adviser or an affiliated person of the Fund’s investment
adviser provides investment advisory services. Directors and executive officers of the Fund do not receive pension or retirement benefits
from the Fund.
Name of Person and
Position with Fund
Aggregate
Compensation
from the Fund
Pension or Retirement
Benefits Accrued as
Part of Fund Expenses
Estimated
Annual Benefits
Upon Retirement
Total Compensation From
Fund and Fund Complex
Paid to Directors
Thomas J. Herzfeld*
$0
$0
$0
$0
Director
John A. Gelety
$34,950
$0
$0
$34,950
Director
Cecilia L. Gondor
$31,950
$0
$0
$31,950
Director
Ann S. Lieff
$31,950
$0
$0
$31,950
Director
Kay W. Tatum
$34,950
$0
$0
$34,950
Director
*
“Interested
person” of the Fund as defined by Section 2(a)(19) of the 1940 Act.
The
Fund does not have a formal policy regarding attendance by directors at annual meetings of stockholders but encourages such attendance.
All members of the Board attended the Fund’s 2023 Annual Meeting.
THE
BOARD, INCLUDING ALL THE DIRECTORS WHO ARE NOT “INTERESTED PERSONS” (AS DEFINED IN THE 1940 ACT) OF THE FUND (THE “INDEPENDENT
DIRECTORS”) RECOMMENDS THAT THE FUND’S STOCKHOLDERS VOTE “FOR” THE ELECTION OF THE NOMINEES FOR DIRECTOR.
ADDITIONAL
INFORMATION
HERZFELD/CUBA
(the “Adviser”), a division of Thomas J. Herzfeld Advisors, Inc., with offices at 119 Washington Avenue, Suite 504, Miami
Beach, Florida 33139, serves as the Fund’s investment adviser pursuant to an investment advisory contract dated September 10, 1993.
The Adviser also provides certain administration services to the Fund pursuant to the terms of the investment advisory contract.
INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM
Tait,
Weller Baker LLP, (“Tait Weller”) an independent registered public accounting firm, has been selected by the Board as
the Fund’s independent auditor for the current fiscal year ending on June 30, 2025. A representative of Tait Weller will be available
at the meeting and will have the opportunity to respond to appropriate questions from stockholders and to make such statements as desired.
8
Independent
Auditor’s Fees
The
following table sets forth the aggregate fees and percentage of total fees charged by the Fund’s independent registered public
accounting firm for the two most recent fiscal years for professional services rendered for: (i) the audit of the annual financial statements
and the review of the financial statements included in the Fund’s report to stockholders; (ii) audit-related services; (iii) tax
compliance, tax advice, and tax planning; (iv) all other products and services provided to the Fund which included matters related to
regulatory issues and preparation of unaudited financial statements.
Fiscal
Year
Ended June 30,
Audit
Fees
Audit
Related Fees
Tax
Fees
All
Other Fees
2024
$36,000
(88.89%)
$0
(0%)
$4,500
(11.11%)
$0
(0%)
2023
$36,000
(88.89%)
$0
(0%)
$4,500
(11.11%)
$0
(0%)
The
Fund’s Audit Committee charter requires that the Audit Committee shall pre-approve all auditing services and permitted non-audit
services (including the fees for such services and terms thereof) to be performed for the Fund by its independent registered public accounting
firm in one of two methods. Under the first method, the engagement to render the services would be entered into pursuant to pre-approval
policies and procedures established by the Audit Committee, provided: (i) the policies and procedures are detailed as to the services
to be performed; (ii) the Audit Committee is informed of each service; and (iii) such policies and procedures do not include delegation
of the Audit Committee’s responsibilities under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)
to the Fund’s management. Under the second method, the engagement to render the services would be presented to and pre-approved
by the Audit Committee (subject to the de minimus exceptions for non-audit services described in Section 10A(i)(1)(B) of the Exchange
Act that are approved by the Audit Committee prior to the completion of the audit). At the present time, the Audit Committee has not
adopted pre-approval policies and procedures, and would use the second method for pre-approval provided for in its charter. All of the
audit, audit-related and tax services described above for which the independent registered public accounting firm billed the Fund fees
for the fiscal years ended June 30, 2023 and 2024 were pre-approved by the Audit Committee.
SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
The
following table set forth, as of September 18, 2024, the beneficial ownership of each current director, each nominee for director, the
Fund’s executive officers, each person known to us to beneficially own 5% or more of the outstanding shares of our common stock,
and the executive officers and directors as a group.
Beneficial
ownership is determined in accordance with the rules of the SEC and includes voting or investment power with respect to the securities.
Percentage of ownership is based on 16,548,313 shares of common stock outstanding as of September 18, 2024.
Unless
otherwise indicated, to our knowledge, each stockholder listed below has sole voting and investment power with respect to the shares
beneficially owned by the stockholder, except to the extent authority is shared by their spouses under applicable law.Unless otherwise
indicated, the address of all executive officers and directors is c/o The Herzfeld Caribbean Basin Fund, Inc., 119 Washington Avenue,
Suite 504, Miami Beach, FL 33139.
The
Fund’s directors are divided into two groups interested directors and independent directors. Interested directors
are “interested persons” as defined in Section2(a)(19) of the 1940 Act.
9
Name
and Address of Beneficial Owner
Number
of Shares
Owned Beneficially
(1)
Percentage
of Class
5%
Holders
None
Interested
Directors
Thomas
J. Herzfeld
1,590,111
(2)
9.6%
Independent
Directors
John
A. Gelety
6,434
*
Cecilia
L. Gondor
41,960
*
Ann
S. Lieff
36,358
*
Kay
W. Tatum
5,027
*
Executive
Officers
Erik
M. Herzfeld
442,270
(3)
2.7%
Thomas
K. Morgan
*
Ryan
M. Paylor
25,134
*
Zachary
P. Richmond
*
Alice
H. Tham
*
Thomas
J. Herzfeld and Erik M. Herzfeld
2,621,880
(4)
15.8%
Executive
officers and directors as a group
4,769,174
28.8%
*
Less
than 1%
(1)
Beneficial
ownership has been determined in accordance with Rule13d-3 of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”).
(2)
According
to a Form 4 filed by Thomas J. Herzfeld on July 17, 2024, Mr. T. Herzfeld beneficially owns with sole power to vote and dispose of 1,590,111
shares of common stock.
(3)
According
to a Form 4 filed by Erik M. Herzfeld on July 17, 2024, Mr. E. Herzfeld beneficially owns with sole power to vote and dispose of 442,270
shares of common stock.
(4)
As
of the Record Date, each of Messrs. T. Herzfeld and E. Herzfeld beneficially owns with shared power to vote and/or dispose of 2,621,880
shares of common stock in his capacity as portfolio manager of investment advisory accounts of the clients of Thomas J. Herzfeld Advisors,
Inc., a registered investment adviser.
Section
30(h) of the 1940 Act and Section 16(a) of the Exchange Act require the Fund’s directors, executive officers and certain other
persons (collectively, “Reporting Persons”), to file with SEC initial reports of ownership and reports of changes in ownership
of equity securities of the Fund. Reporting Persons are required by SEC regulations to furnish the Fund with copies of all Section 16(a)
forms they file. To the Fund’s knowledge, based solely on review of the copies of such reports furnished to the Fund during the
fiscal year ended June 30, 2024, all Section 16(a) filing requirements applicable to the Reporting Persons were complied with.
STOCKHOLDER
PROPOSALS
Notice
is hereby given that for a stockholder proposal to be considered for inclusion in the Fund’s proxy materials relating to its 2025
Annual Meeting of Stockholders, pursuant to Rule 14a-8 under the Exchange Act, the stockholder must deliver the proposal to the offices
of the Fund by June 2, 2025. In the event the Fund moves the date of its 2025 Annual Meeting of Stockholders by more than 30 days from
the anniversary of the 2024 Annual Meeting of Stockholders, stockholder submissions of proposals for inclusion in the Fund’s proxy
statement and proxy card for the 2025 Annual Meeting of Stockholders pursuant to Rule 14a-8 under the Exchange Act must be delivered
to the Fund at a reasonable time before the Fund begins to print and send its proxy materials in connection with the 2025 Annual Meeting
of Stockholders. Under Rule 14a-8, a stockholder proposal, including any accompanying supporting statement, may not exceed 500 words.
Additionally, a stockholder desiring to submit a proposal must be: (i) a record or beneficial owner of shares with a market value of
at least $2,000 and must have held such shares for at least three years, (ii) a record or beneficial owner of shares with a market value
of at least $15,000 and must have held such shares for at least two years, or (iii) a record or beneficial owner of shares with a market
value of at least $25,000 and must have held such shares for at least one year. Further, the stockholder must continue to hold such shares
through the date on which the meeting is held. Documentary support regarding the foregoing must be provided along with the proposal.
There are additional requirements regarding proposals of stockholders, and a stockholder contemplating submission of a proposal is referred
to Rule 14a-8 promulgated under the Exchange Act. The timely submission of a proposal does not guarantee its inclusion in the Fund’s
proxy materials.
A
stockholder who wishes to make a proposal at the 2025 Annual Meeting of Stockholders without including the proposal in the Fund’s
proxy statement must notify the Fund, and the Fund’s officers, of such proposal no earlier than August 9, 2025 (90 days prior),
and no
10
later than September 8, 2025 (60 days prior, assuming a November 14, 2025 meeting.) If a stockholder fails to give notice by the
later date, then the persons named as proxies in the proxies solicited by the Board for the 2025 Annual Meeting of Stockholders may exercise
discretionary voting power with respect to any such proposal.
REPORTS
TO STOCKHOLDERS AND FINANCIAL STATEMENTS
The
annual report to Stockholders of the Fund, including audited financial statements of the Fund for the fiscal year ended June 30, 2024,
should be read in conjunction with this proxy statement but is not part of the proxy soliciting material. A copy of the annual report
may be obtained from the Fund, without charge, by visiting www.herzfeld.com/cuba, contacting the Fund in writing at the address on the
cover of this proxy statement, or calling 800-TJH-FUND (854-3863) or 305-777-1660.
INFORMATION
ABOUT ATTENDING THE MEETING
Attendance
at the Annual Meeting is limited to stockholders (or their authorized representatives) as of the Record Date. All attendees should pre-register
and obtain an admission ticket. Pre-registration is intended to facilitate entry through security at the Annual Meeting. Failure to pre-register
may result in a delay in gaining entry into the meeting. Valid, government-issued photographic identification is required to enter the
meeting. Cameras, audio and video recorders and similar electronic recording devices will not be allowed in the meeting room. We will
also request that all cellular phones, smartphones, tablets, pagers, laptops, and other communication and similar devices be turned off.
If
you would like to attend the Annual Meeting, please follow the instructions below to pre-register by October 27, 2024.
Pre-Registration
Instructions
If
you are a registered stockholder (your shares are held in your name), you may pre-register and obtain an admission ticket by contacting
us and providing your name as it appears on your stock ownership records and your mailing address. If a family member is attending with
you, please indicate that when you pre-register.
If
you are a beneficial owner (your shares are held through a broker or bank) you may pre-register and obtain an admission ticket by contacting
us and providing your name and mailing address, and evidence of your stock ownership as of the Record Date. A copy of your brokerage
or bank statement will suffice as evidence of ownership, or you can obtain a letter from your broker or bank. If a family member is attending
with you, please indicate that when you pre-register.
If
you are a stockholder as of the Record Date and intend to appoint an authorized representative to attend the meeting on your behalf,
you may pre-register and obtain an admission ticket by submitting a request to us and providing: your name and mailing address, the name
and mailing address of your authorized representative, evidence of stock ownership as of the Record Date, and a signed authorization
appointing such individual to be your authorized representative at the meeting.
To
pre-register for the meeting and obtain an admission ticket, you can write to us at The Herzfeld Caribbean Basin Fund, Inc., 119 Washington
Avenue, Suite 504, Miami Beach, FL 33139, email us at info@herzfeld.com, or call us at 800-TJH-FUND (854-3863) or 305-777-1660.
11
OTHER
MATTERS
Management
of the Fund does not know of any matters to be presented at the Annual Meeting other than those mentioned in this proxy statement. If
any other business should come before the meeting, the proxy will vote thereon in accordance with his best judgment.
By
Order of the Directors,
Erik
M. Herzfeld
President
The
Herzfeld Caribbean Basin Fund, Inc.
Dated:
September 30, 2024
IF
YOU CANNOT ATTEND THE ANNUAL MEETING, IT IS REQUESTED THAT YOU COMPLETE AND SIGN THE ENCLOSED PROXY AND RETURN IT IN THE ENVELOPE PROVIDED
SO THAT THE MEETING MAY BE HELD AND ACTION TAKEN ON THE MATTERS DESCRIBED HEREIN WITH THE GREATEST POSSIBLE NUMBER OF SHARES PARTICIPATING.
12
THOMAS
J. HERZFELD ADVISORS, INC.
119 WASHINGTON AVENUE, SUITE 504
MIAMI BEACH, FLORIDA 33139
SCAN
TO
VIEW MATERIALS VOTE
To
vote by Mail
1)Read
the Proxy Statement.
2)Check
the appropriate box on the proxy card below.
3)Sign
and date the proxy card.
4)Return
the proxy card in the envelope provided.
TO
VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS:
V56184-P18084
KEEP
THIS PORTION FOR YOUR RECORDS
DETACH
AND RETURN THIS PORTION ONLY
The
Board of Directors recommends a vote
FOR
the listed nominees in Proposal 1:
For
All
Withhold
All
For
All
Except
To withhold
authority to vote for any individual nominee(s), mark “For All Except” and write the name(s) of the nominee(s) on the line
below.
1.ELECTION OF CLASS I DIRECTORS
Nominees:
o
o
o
01)Ms. Cecilia L. Gondor
02) Ms.
Kay W. Tatum
2.IN THEIR DISCRETION, THE PROXY IS AUTHORIZED TO VOTE UPON SUCH OTHER BUSINESS AS MAY PROPERLY COME BEFORE THE MEETING.
ALL
PROXIES WILL BE VOTED AND WILL BE VOTED IN ACCORDANCE WITH THE INSTRUCTIONS NOTED HEREON. IF INSTRUCTIONS ARE NOT GIVEN, THIS PROXY
WILL BE TREATED AS GRANTING AUTHORITY TO VOTE “FOR” PROPOSAL 1, IF PROPERLY PRESENTED AT THE MEETING.
PLEASE
SIGN, DATE, AND RETURN PROMPTLY IN ENCLOSED ENVELOPE.
NOTE: Please sign exactly as your name appears on this Proxy. When signing in a fiduciary capacity, such as executor, administrator,
trustee, attorney, guardian, etc., please so indicate. Corporate or partnership proxies should be signed by an authorized person indicating
the person’s title.
Signature
[PLEASE SIGN WITHIN BOX]
Date
Signature
[Joint Owners]
Date
Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting:
The Proxy Statement and Annual Report are available at www.herzfeld.com/cuba.
V56185-P18084
Vote this proxy card TODAY!
Your prompt response will save the expense
of additional mailings.
Vote by Mail!
MAIL: Return the signed proxy card in the enclosed envelope.
PROXY
SOLICITED BY THE BOARD OF DIRECTORS OF THE HERZFELD CARIBBEAN BASIN FUND, INC.
The
undersigned hereby appoints Erik M. Herzfeld, as attorney-in-fact, with full powers of substitution and revocation, to attend the Annual
Meeting of Stockholders of The Herzfeld Caribbean Basin Fund, Inc. on November 14, 2024 and any adjournments thereof and there at to
vote all shares which the undersigned would be entitled to vote if personally present, upon the matters listed on the reverse side, as
set forth in the Notice of Annual Meeting of Stockholders, and upon such other business as may properly come before the meeting or any
adjournment thereof.
If
said attorney or any substitutes shall be present and vote at said meeting or any adjournment thereof, a majority of them so present
and voting (or if only one be present and voting, then that one) shall have and exercise all the powers hereby granted. The undersigned
revokes any proxy or proxies heretofore given to vote such shares at said meeting or any adjournment thereof.
CONTINUED
AND TO BE SIGNED
ON REVERSE SIDE
TABLE OF CONTENTS
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR
WHICH
THE 13F WAS FILED.
FUND
NUMBER OF SHARES
VALUE ($)
PUT OR CALL
Directors of HERZFELD CARIBBEAN BASIN FUND INC - as per the
latest proxy Beta
Customers and Suppliers of HERZFELD CARIBBEAN BASIN FUND INC
Beta
No Customers Found
No Suppliers Found
Bonds of HERZFELD CARIBBEAN BASIN FUND INC
Price Graph
Price
Yield
Insider Ownership of HERZFELD CARIBBEAN BASIN FUND INC
company Beta
Owner
Position
Direct Shares
Indirect Shares
AI Insights
Summary Financials of HERZFELD CARIBBEAN BASIN FUND INC
Beta
(We are using algorithms to extract and display detailed data. This is a hard problem and we are working continuously to classify data in an accurate and useful manner.)
